Oremten

Medicinal product

(Invented) name

Oremten

Active substance (s)

Emtricitabinas/Tenofoviro dizoproksilis

Strength

200 mg/245 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AR03, Tenofovir disoproxil and emtricitabine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-10-15

Date of renewal

Documents

3659_Oremten 200-245mg_pl_deng_tab_PL_2026-10-15.docx

3659_Oremten 200-245mg_pl_deng_tab_PZ_2026-10-15.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Emtricitabinas	200 mg
Tenofoviro dizoproksilis	245 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122583	108693	1108693	lizdinė plokštelė	N30		Receptinis	LT/L/26/3659/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-10-15	Registruotas